Schulten Andre
SEC CIK 1844763 · EDGAR
BoughtSold
Most active insiders at PG, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Moeller Jon R | Exec. COB, Dir | — | $29.90M |
| 2 | Pritchard Marc S. | Chief Brand Off | — | $15.08M |
| 3 | Coombe Gary A | CEO - Grooming | — | $6.40M |
| 4 | Aguilar Moses Victor Javier | Chf Rsch, Dev, Innov Off | — | $3.34M |
| 5 | Purushothaman Balaji | CHRO | — | $2.42M |
| 6 | Whaley Susan Street | CLO, Secy | — | $2.22M |
| 7 | Francisco Ma. Fatima | CEO - Baby, Fem, Family Care | — | $2.18M |
| 8 | Jejurikar Shailesh | COO, Dir | — | $1.49M |
| 9 | Schulten Andre | CFO | — | $1.42M |
| 10 | Raman Sundar G. | CEO-Fabric, Home Care | — | $491.3K |
Transactions 42
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-24 15:44 | 2026-08-20 | PG | Procter & Gamble | Schulten Andre | CFO | S - Sale | $143.79 | -5,402 | 63.0K | -8% | -$776.8K | |
| D | 2026-08-21 14:26 | 2026-08-19 | PG | Procter & Gamble | Schulten Andre | CFO | A - Grant | $0.00 | +14.5K | 68.4K | +27% | $0 |
| D | 2026-05-08 18:12 | 2026-05-06 | ETN | Eaton Corporation | Schulten Andre | Dir | M - OptEx | $0.00 | +621 | 816 | +318% | $0 |
| D | 2026-05-08 18:12 | 2026-05-06 | ETN | Eaton Corporation | Schulten Andre | Dir | F - Tax | $416.50 | -150 | 666 | -18% | -$62.5K |
| D | 2025-12-05 | 2025-12-03 | PG | Procter & Gamble | Schulten Andre | CFO | M - OptEx | $144.35 | +88.63 | 53.5K | +0.2% | +$12.8K |
| DM | 2025-12-05 | 2025-12-03 | PG | Procter & Gamble | Schulten Andre | CFO | F - Tax | $144.35 | -872.62 | 53.5K | -2% | -$126.0K |
| I | 2025-11-12 | 2025-11-10 | PG | Procter & Gamble | Schulten Andre | CFO | S - Sale | $146.37 | -1.30 | 6,869 | -0.0% | -$190.28 |
| 2025-10-06 | 2025-10-02 | PG | Procter & Gamble | Schulten Andre | CFO | S - Sale | $152.23 | -4,252 | 54.0K | -7% | -$647.3K | |
| D | 2025-10-02 | 2025-10-01 | PG | Procter & Gamble | Schulten Andre | CFO | A - Grant | $0.00 | +5,602 | 58.2K | +11% | $0 |
| D | 2025-08-20 | 2025-08-19 | PG | Procter & Gamble | Schulten Andre | CFO | S - Sale | $157.27 | -11.6K | 52.6K | -18% | -$1.83M |
| D | 2025-08-20 | 2025-08-18 | PG | Procter & Gamble | Schulten Andre | CFO | A - Grant | $0.00 | +27.9K | 64.3K | +77% | $0 |
| D | 2025-05-05 | 2025-05-02 | ETN | Eaton Corporation | Schulten Andre | Dir | F - Tax | $295.28 | -62 | 194 | -24% | -$18.3K |
| D | 2025-05-05 | 2025-05-02 | ETN | Eaton Corporation | Schulten Andre | Dir | M - OptEx | $0.00 | +256 | 256 | New | $0 |
| D | 2024-12-20 | 2024-12-19 | PG | Procter & Gamble | Schulten Andre | CFO | F - Tax | $169.79 | -70.42 | 35.8K | -0.2% | -$12.0K |
| D | 2024-12-20 | 2024-12-19 | PG | Procter & Gamble | Schulten Andre | CFO | M - OptEx | $169.79 | +70.42 | 35.9K | +0.2% | +$12.0K |
| D | 2024-10-03 | 2024-10-02 | PG | Procter & Gamble | Schulten Andre | CFO | S - Sale | $171.65 | -1,569 | 35.6K | -4% | -$269.3K |
| 2024-08-27 | 2024-08-26 | PG | Procter & Gamble | Schulten Andre | CFO | S - Sale | $170.00 | -13.0K | 37.2K | -26% | -$2.22M | |
| D | 2024-08-22 | 2024-08-20 | PG | Procter & Gamble | Schulten Andre | CFO | S - Sale | $169.22 | -9,150 | 50.2K | -15% | -$1.55M |
| 2024-08-20 | 2024-08-19 | PG | Procter & Gamble | Schulten Andre | CFO | A - Grant | $0.00 | +22.2K | 59.2K | +60% | $0 | |
| D | 2023-12-08 | 2023-12-06 | PG | Procter & Gamble | Schulten Andre | CFO | F - Tax | $149.40 | -69.85 | 36.6K | -0.2% | -$10.4K |
| D | 2023-12-08 | 2023-12-06 | PG | Procter & Gamble | Schulten Andre | CFO | M - OptEx | $149.40 | +69.85 | 36.7K | +0.2% | +$10.4K |
| DM | 2023-11-07 | 2023-11-06 | PG | Procter & Gamble | Schulten Andre | CFO | S - Sale+OE | $150.61 | -40.3K | 36.5K | -53% | -$6.07M |
| DM | 2023-11-07 | 2023-11-06 | PG | Procter & Gamble | Schulten Andre | CFO | M - OptEx | $82.46 | +40.3K | 54.6K | +283% | +$3.32M |
| D | 2023-10-04 | 2023-10-02 | PG | Procter & Gamble | Schulten Andre | CFO | A - Grant | $0.00 | +9,686 | 36.5K | +36% | $0 |
| 2023-10-03 | 2023-10-02 | PG | Procter & Gamble | Schulten Andre | CFO | S - Sale | $144.97 | -1,599 | 26.8K | -6% | -$231.8K | |
| 2023-08-18 | 2023-08-17 | PG | Procter & Gamble | Schulten Andre | CFO | S - Sale | $152.85 | -806 | 28.4K | -3% | -$123.2K | |
| D | 2023-08-18 | 2023-08-16 | PG | Procter & Gamble | Schulten Andre | CFO | A - Grant | $0.00 | +1,768 | 29.2K | +6% | $0 |
| D | 2023-04-25 | 2023-04-24 | PG | Procter & Gamble | Schulten Andre | CFO | M - OptEx | $78.66 | +17.2K | 44.3K | +64% | +$1.35M |
| DM | 2023-04-25 | 2023-04-24 | PG | Procter & Gamble | Schulten Andre | CFO | S - Sale+OE | $155.27 | -25.2K | 27.1K | -48% | -$3.92M |
| D | 2023-03-02 | 2023-03-01 | PG | Procter & Gamble | Schulten Andre | CFO | S - Sale | $137.34 | -1,311 | 35.1K | -4% | -$180.1K |
| D | 2022-12-09 | 2022-12-07 | PG | Procter & Gamble | Schulten Andre | CFO | M - OptEx | $149.18 | +60.76 | 36.3K | +0.2% | +$9,064 |
| D | 2022-12-09 | 2022-12-07 | PG | Procter & Gamble | Schulten Andre | CFO | F - Tax | $149.18 | -60.76 | 36.3K | -0.2% | -$9,064 |
| D | 2022-10-05 | 2022-10-03 | PG | Procter & Gamble | Schulten Andre | CFO | A - Grant | $0.00 | +8,755 | 36.1K | +32% | $0 |
| D | 2022-08-18 | 2022-08-17 | PG | Procter & Gamble | Schulten Andre | CFO | S - Sale | $149.33 | -987 | 27.3K | -3% | -$147.4K |
| D | 2022-08-18 | 2022-08-16 | PG | Procter & Gamble | Schulten Andre | CFO | A - Grant | $0.00 | +2,864 | 28.3K | +11% | $0 |
| D | 2022-03-03 | 2022-03-01 | PG | Procter & Gamble | Schulten Andre | CFO | S - Sale | $153.51 | -1,335 | 25.2K | -5% | -$204.9K |
| D | 2021-12-07 | 2021-12-06 | PG | Procter & Gamble | Schulten Andre | CFO | M - OptEx | $148.83 | +39.47 | 26.5K | +0.1% | +$5,874 |
| D | 2021-12-07 | 2021-12-06 | PG | Procter & Gamble | Schulten Andre | CFO | F - Tax | $148.83 | -39.47 | 26.4K | -0.1% | -$5,874 |
| D | 2021-10-05 | 2021-10-01 | PG | Procter & Gamble | Schulten Andre | CFO | A - Grant | $0.00 | +3,224 | 26.3K | +14% | $0 |
| 2021-08-23 | 2021-08-23 | PG | Procter & Gamble | Schulten Andre | CFO | S - Sale | $144.50 | -1,513 | 23.1K | -6% | -$218.6K | |
| 2021-08-19 | 2021-08-17 | PG | Procter & Gamble | Schulten Andre | CFO | S - Sale | $144.37 | -1,010 | 24.6K | -4% | -$145.8K | |
| 2021-08-19 | 2021-08-17 | PG | Procter & Gamble | Schulten Andre | CFO | A - Grant | $0.00 | +2,523 | 25.6K | +11% | $0 |
Purchase Sale Sale after option exercise All abbreviations